IDDI is pleased to invite you to an exceptional complimentary Lunch & Learn enhanced by
the presence of Prof Christopher Sweeney, MBBS as Keynote Speaker.
|
|
|
|
|
|
Validating Surrogate Endpoints in Oncology: From Theory to Practice
Tuesday, October 8, 2019: 11:30am-2:00pm
|
|
|
|
|
|
|
|
|
A Clinical Perspective on Surrogate Endpoints in Prostate Cancer
Prof Christopher Sweeney, MBBS, Professor of Medicine, Harvard Medical School and Medical Oncologist, Dana-Farber Cancer Institute
|
|
|
|
|
|
Statistical Considerations on Surrogate Endpoints
Prof Tomasz Burzykowski, PhD, VP Research IDDI and Professor of Biostatistics, Hasselt University, Belgium
|
|
|
|
|
|
|
11:30am: Welcome
11:45am - 12:30pm: Wolfgang Puck Catering Lunch
12:30 - 1:00pm: A Clinical Perspective on Surrogate Endpoints in Prostate Cancer, Prof C. Sweeney, MBBS
1:00 - 1:30pm: Statistical Considerations on Surrogate Endpoints, Prof T. Burzykowski, PhD
1:30 - 2:00pm: QA / Wrap up
|
|
|
|
|
|
- The theoretical requirements for validating surrogate endpoints, as currently used by FDA
- The steps entailed in surrogate validation
- The difference between patient-level and trial-level surrogacy
|
|
|
|
|
|
1 Science Park, Boston, MA 02114
Parking is free of charge
|
|
|
|
|
|
We hope that you can come! Please reply with your attendance by October 1, 2019!
|
|
|
|
|
|
|
|
|
